Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118 | 341 | 414 | 447 | 7 |
| Other current assets | 0 | 0 | 0 | 0 | 221 |
| TOTAL | $340 | $440 | $555 | $666 | $257 |
| Non-Current Assets | |||||
| Investments And Advances | 119,417 | 117,807 | 116,609 | 116,296 | 0 |
| TOTAL | $119,417 | $117,807 | $116,609 | $116,296 | $N/A |
| Total Assets | $119,757 | $118,247 | $117,164 | $116,962 | $257 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 307 | 140 | 60 | 30 | 41 |
| Other current liabilities | 63,170 | N/A | N/A | N/A | N/A |
| TOTAL | $64,544 | $506 | $218 | $69 | $241 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59,917 | 121,706 | 120,953 | 121,173 | 0 |
| TOTAL | $60,090 | $121,785 | $120,953 | $121,173 | $N/A |
| Total Liabilities | $124,634 | $122,291 | $121,171 | $121,242 | $241 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,802 | 8,802 | 14,905 | 14,905 | 14,905 |
| Retained earnings | -4,878 | -4,045 | -4,008 | -4,280 | -9 |
| TOTAL | $-4,878 | $-4,045 | $-4,008 | $-4,280 | $16 |
| Total Liabilities And Equity | $119,757 | $118,247 | $117,164 | $116,962 | $257 |